<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">20700108</PMID>
        <DateCompleted>
            <Year>2011</Year>
            <Month>02</Month>
            <Day>02</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2020</Year>
            <Month>03</Month>
            <Day>05</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1759-4782</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>7</Volume>
                    <Issue>9</Issue>
                    <PubDate>
                        <Year>2010</Year>
                        <Month>Sep</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Nature reviews. Clinical oncology</Title>
                <ISOAbbreviation>Nat Rev Clin Oncol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Making the best of PARP inhibitors in ovarian cancer.</ArticleTitle>
            <Pagination>
                <MedlinePgn>508-19</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1038/nrclinonc.2010.116</ELocationID>
            <Abstract>
                <AbstractText>Drugs that inhibit the enzyme poly(ADP-ribose)polymerase (PARP) are showing considerable promise for the treatment of cancers that have mutations in the BRCA1 or BRCA2 tumor suppressors. This therapeutic approach exploits a synthetic lethal strategy to target the specific DNA repair pathway in these tumors. High-grade ovarian cancers have a generally poor prognosis, and accumulating evidence suggests that mutations in BRCA1 or BRCA2, or silencing of BRCA1 by promoter methylation, may be common in this disease. Here, we consider how the potential benefit of PARP inhibitors might be maximized in ovarian cancer. We suggest that it will be crucial to explore novel therapeutic trial strategies and drug combinations, and incorporate robust biomarkers predictive of response if these drugs are to reach their full potential.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Banerjee</LastName>
                    <ForeName>Susana</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kaye</LastName>
                    <ForeName>Stan B</ForeName>
                    <Initials>SB</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ashworth</LastName>
                    <ForeName>Alan</ForeName>
                    <Initials>A</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>BREAST CANCER NOW RESEARCH CENTRE</GrantID>
                    <Acronym>BBC_</Acronym>
                    <Agency>Breast Cancer Now</Agency>
                    <Country>United Kingdom</Country>
                </Grant>
                <Grant>
                    <Acronym>CRUK_</Acronym>
                    <Agency>Cancer Research UK</Agency>
                    <Country>United Kingdom</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2010</Year>
                <Month>08</Month>
                <Day>10</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Nat Rev Clin Oncol</MedlineTA>
            <NlmUniqueID>101500077</NlmUniqueID>
            <ISSNLinking>1759-4774</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000970">Antineoplastic Agents</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D019313">BRCA1 Protein</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="C492913">BRCA1 protein, human</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D024682">BRCA2 Protein</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="C551750">BRCA2 protein, human</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D004791">Enzyme Inhibitors</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000067856">Poly(ADP-ribose) Polymerase Inhibitors</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D042461">Vascular Endothelial Growth Factor A</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 2.4.2.30</RegistryNumber>
                <NameOfSubstance UI="D011065">Poly(ADP-ribose) Polymerases</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000970" MajorTopicYN="N">Antineoplastic Agents</DescriptorName>
                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019313" MajorTopicYN="N">BRCA1 Protein</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D024682" MajorTopicYN="N">BRCA2 Protein</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019175" MajorTopicYN="N">DNA Methylation</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019008" MajorTopicYN="N">Drug Resistance, Neoplasm</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004359" MajorTopicYN="N">Drug Therapy, Combination</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004791" MajorTopicYN="N">Enzyme Inhibitors</DescriptorName>
                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010051" MajorTopicYN="N">Ovarian Neoplasms</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
                <QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000067856" MajorTopicYN="Y">Poly(ADP-ribose) Polymerase Inhibitors</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011065" MajorTopicYN="N">Poly(ADP-ribose) Polymerases</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D042461" MajorTopicYN="N">Vascular Endothelial Growth Factor A</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2010</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2010</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2011</Year>
                <Month>2</Month>
                <Day>3</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">20700108</ArticleId>
            <ArticleId IdType="pii">nrclinonc.2010.116</ArticleId>
            <ArticleId IdType="doi">10.1038/nrclinonc.2010.116</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Int J Mol Med. 2008 Jul;22(1):113-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18575783</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMC Genomics. 2005 Oct 04;6:139</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16202152</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 2008 Jan 1;26(1):9-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18165631</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 2007 Nov 20;25(33):5165-71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18024863</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2005 Oct 20;353(16):1659-72</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16236737</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arterioscler Thromb Vasc Biol. 2008 Apr;28(4):711-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18239155</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Natl Cancer Inst. 2000 May 3;92(9):699-708</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10793106</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>EMBO Mol Med. 2009 Sep;1(6-7):315-22</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20049735</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 2008 Dec 1;26(34):5530-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18955455</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 2008 Jan 1;26(1):20-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18165636</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Res. 2008 Apr 15;68(8):2581-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18413725</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Cell Biol. 2002 Jan;22(2):669-79</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11756561</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 2002 Jan 15;20(2):463-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11786575</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMC Cancer. 2008 Jan 22;8:17</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18208621</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Med. 2003 May;9(5):568-74</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12692539</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Res. 2006 Aug 15;66(16):8109-15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16912188</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2000 May 3;283(17):2260-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10807385</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Trends Biochem Sci. 1999 Jul;24(7):271-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10390616</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19474385</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Carcinogenesis. 2005 Oct;26(10):1651-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15917310</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Cell. 1999 Oct;4(4):511-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10549283</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 2010 Aug 1;28(22):3570-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20606085</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2009 Feb 5;360(6):563-72</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19196673</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 2004 Mar 15;22(6):1040-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15020606</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2005 Apr 14;434(7035):913-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15829966</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Cancer Res. 2007 May 1;13(9):2728-37</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17473206</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Oncol. 2005;16 Suppl 8:viii7-viii12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16239238</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Bioessays. 2004 Aug;26(8):882-93</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15273990</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Cell. 1998 Feb;1(3):347-57</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9660919</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2009 Jul 9;361(2):123-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19553641</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Genetics. 1946 May;31:269-90</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20985721</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>EMBO J. 1998 Sep 15;17 (18):5497-508</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9736627</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Cancer. 2005 Sep;5(9):689-98</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16110319</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cold Spring Harb Symp Quant Biol. 2005;70:139-48</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16869747</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 2007 Oct 10;25(29):4557-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17876013</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Biol Ther. 2005 Sep;4(9):934-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16251802</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Res. 1998 Aug 1;58(15):3193-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9699640</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biochem Biophys Res Commun. 2006 Nov 17;350(2):352-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17007818</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Cell Biol. 2004 Nov;24(21):9305-16</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15485900</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2008 Feb 28;451(7182):1116-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18264087</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2009 Mar 28;373(9669):1097-104</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19303137</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer. 2000 Jun 1;88(11):2584-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10861437</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Cancer Ther. 2005 Sep;4(9):1364-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16170028</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 1996 Nov 7;335(19):1413-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8875917</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2008 Feb 28;451(7182):1111-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18264088</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2003 Jun 5;348(23):2339-47</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12788999</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Res. 2005 Oct 1;65(19):8961-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16204069</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer. 2005 Dec 15;104(12):2807-16</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16284991</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Cancer Res. 2000 Jul;6(7):2860-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10914735</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 1996 Jan 4;334(1):1-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7494563</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 2009 Feb 10;27(5):672-80</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19114685</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer. 2003 May 1;97(9):2187-95</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12712470</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Res. 2009 Aug 15;69(16):6381-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19654294</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer. 2008 May 15;112(10):2211-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18344211</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Cell Biol. 2003 Aug;23(16):5706-15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12897142</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biochem Biophys Res Commun. 1963 Apr 2;11:39-43</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14019961</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Natl Cancer Inst. 2004 Jan 7;96(1):56-67</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14709739</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Cancer. 2004 Oct;4(10):814-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15510162</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>EMBO J. 2001 Sep 3;20(17):4704-16</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11532935</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 2010 May 20;28(15):2512-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20406929</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 2003 Sep 1;21(17):3194-200</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12860964</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Cell. 2001 Feb;7(2):263-72</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11239455</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biochem Pharmacol. 2009 Apr 15;77(8):1348-57</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19426673</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gynecol Oncol. 2009 Jul;114(1):48-52</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19361839</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 2007 Nov 20;25(33):5180-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18024865</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2005 Apr 14;434(7035):917-21</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15829967</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Cancer. 2007 Sep;43(14 ):2124-33</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17714938</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Oncol Rep. 2008 Nov;10(6):519-23</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18928667</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Natl Cancer Inst. 2003 Sep 3;95(17):1320-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12953086</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 1991 Mar;9(3):389-93</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1999708</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Cell. 2005 Mar 18;17 (6):885-94</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15780943</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2008 Nov 4;105(44):17079-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18971340</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMC Cell Biol. 2003 Jul 16;4:7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12866953</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Cancer Res. 2007 Dec 15;13(24):7413-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18094425</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2001 May 17;411(6835):366-74</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11357144</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Adv Anat Pathol. 2009 Sep;16(5):267-82</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19700937</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>
